SOLBRIVA
Live / Allowed — Published for opposition (as of 24 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99462072
- Mark type
- Stylized text
- Filed
- 24 Oct 2025
- Published for opposition
- 24 Mar 2026
- Attorney of record
- David M. Sigmon
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals, namely anti-inflammatories in the nature of sulindac in tablet form
Owner
- Pangea Pharmaceuticals, LLC, Brielle, NJ, US
- Pangea Pharmaceuticals, LLC, Brielle, NJ, US
Prosecution history
- 24 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Mar 2026 — PUBLISHED FOR OPPOSITION
- 18 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Dec 2025 — NON-FINAL ACTION E-MAILED
- 03 Dec 2025 — NON-FINAL ACTION WRITTEN
- 01 Dec 2025 — ASSIGNED TO EXAMINER
- 28 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Oct 2025 — APPLICATION FILING RECEIPT MAILED